Phase II of BAX2398/5-FU/Calcium Levofolinate in Pancreatic Cancer

NCT02697058 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Cancer

Interventions

BIOLOGICAL: BAX2398 + 5-FU/calcium levofolinate
DRUG: 5-FU/calcium levofolinate

Sponsor

Institut de Recherches Internationales Servier

Collaborators

[object Object]